Entity
  • MaxCyte, Inc.

    Created in 1999
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    1,191 8,769
  • Activities

  • Technologies

  • Entity types

  • Location

    9713 Key W Ave #400, Rockville, MD 20850, USA

    Rockville

    United States of America

  • Employees

    Scale: 51-200

    Estimated: 141

  • Engaged corporates

    4
    1 2
  • Added in Motherbase

    3 years, 1 month ago
Description
  • Value proposition

    Let's Build Better Cells Together

    We invest in our partners early on, working side by side in optimizing their processes to derisk their path to the clinic faster. Our ExPERTTM platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATxTM, STxTM, GTxTM and VLx TM; a portfolio of proprietary related processing assemblies or disposables; and software protocols, all supported by a robust worldwide intellectual property portfolio. By providing our partners with the right technology, as well as technical and regulatory support, we aim to guide them on their journey to transform human health.

    Vaccine Development, Protein Production, Transfection, Cell Therapy, Gene Therapy, Cancer, Immunotherapy, Electroporation, MyExpertPlatform, Tcell, NKcell, Bispecifics, Gene Editing, Cancer Research, Immuno-oncology, Stem Cell, CARMA, Cell Engineering, Biotechnology, Life Sciences, and Innovation

  • MaxCyte | Best-in-Class Electroporation Systems

    Our collection of ExPERT™ instruments delivers engineering excellence by combining high efficiency and cell viability with seamless scalability.

  • https://maxcyte.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Vertex Pharmaceuticals
Vertex Pharmaceuticals
Biotechnology, Biotechnology Research
Vertex Pharmaceuticals
Biotechnology, Biotechnology Research
Other

22 Jan 2024


Biogen
Biogen
Biotechnology, Biotechnology Research
Biogen
Biotechnology, Biotechnology Research
Other

13 May 2021


Sofinnova Partners
Sofinnova Partners
Financial Services
Sofinnova Partners
Financial Services
Not capitalistic
Partnership
Event

2 Jun 2021


Nasdaq
Nasdaq
Finance, Financial Services
Nasdaq
Finance, Financial Services
Not capitalistic
Partnership
Event

5 Oct 2021


Similar entities
Loading...
Loading...
Social network dynamics